SUTRO BIOPHARMA INC. - COMMON STOCK

Sutro Biopharma Announces the Departure of President of Research & Chief Scientific Officer

27 апр 2023 16:30:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Presents Preclinical Data for its ROR1 Targeting Antibody Drug Conjugate STRO-003 at the AACR Annual Meeting 2023

18 апр 2023 13:30:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Reports Full Year 2022 Financial Results, Business Highlights and Select Anticipated Milestones

30 мар 2023 16:30:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17 мар 2023 16:01:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma to Present at the Cowen 43rd Annual Health Care Conference

01 мар 2023 08:00:01 Источник Nasdaq GlobeNewswire

Sutro Biopharma Appoints Dr. Anne Borgman as Chief Medical Officer  

28 фев 2023 08:00:03 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

17 фев 2023 16:01:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Update from STRO-002, Luveltamab Tazevibulin (Luvelta), Phase 1 Dose-Expansion Study and Registrational Plans in Advanced Ovarian Cancer

09 янв 2023 16:05:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma to Present at the 41st Annual J.P. Morgan Healthcare Conference

04 янв 2023 08:00:01 Источник Nasdaq GlobeNewswire

Sutro Biopharma to Provide Data Update on STRO-002 and Plans for Registrational Path Forward in Advanced Ovarian Cancer

21 дек 2022 08:00:01 Источник Nasdaq GlobeNewswire

Sutro Biopharma and Vaxcyte Enter into Option Grant Agreement for the Development and Manufacturing Rights of Cell-Free Extract

20 дек 2022 16:05:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Presentation of STRO-002 Data from the Compassionate Use Program in Pediatric Patients with Relapsed/Refractory CBF/GLIS AML at ASH 2022

10 дек 2022 10:30:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

23 ноя 2022 07:00:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Reports Third Quarter 2022 Financial Results, Business Highlights and Select Anticipated Milestones

08 ноя 2022 16:30:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Oral Presentation at the 64th American Society of Hematology Annual Meeting and Exposition

03 ноя 2022 09:00:01 Источник Nasdaq GlobeNewswire

Sutro Biopharma to Participate in Upcoming Investor Conferences

02 ноя 2022 07:00:01 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Departure of Chief Medical Officer

24 окт 2022 07:00:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma to Present at the 2022 Wells Fargo Healthcare Conference

01 сен 2022 07:00:01 Источник Nasdaq GlobeNewswire

Sutro Biopharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

19 авг 2022 16:01:00 Источник Nasdaq GlobeNewswire

Sutro Biopharma Reports Second Quarter 2022 Financial Results, Business Highlights and Anticipated Milestones

08 авг 2022 16:30:00 Источник Nasdaq GlobeNewswire